These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8520332)

  • 1. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal screening for cystic fibrosis.
    Cuckle H; Quirke P; Sehmi I; Lewis F; Murray J; Cross D; Cuckle P; Ozols B
    Br J Obstet Gynaecol; 1996 Aug; 103(8):795-9. PubMed ID: 8760710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of antenatal screening for cystic fibrosis. Couple screening should be preferred for medical reasons.
    Morris J
    BMJ; 1996 Apr; 312(7035):908-9; author reply 910. PubMed ID: 8611894
    [No Abstract]   [Full Text] [Related]  

  • 5. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs, effects, and savings of screening for cystic fibrosis gene carriers.
    Wildhagen MF; Hilderink HB; Verzijl JG; Verheij JB; Kooij L; Tijmstra T; ten Kate LP; Habbema JD
    J Epidemiol Community Health; 1998 Jul; 52(7):459-67. PubMed ID: 9799881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antenatal screening for haemoglobinopathies in primary care: a cohort study and cluster randomised trial to inform a simulation model. The Screening for Haemoglobinopathies in First Trimester (SHIFT) trial.
    Dormandy E; Bryan S; Gulliford MC; Roberts TE; Ades AE; Calnan M; Atkin K; Karnon J; Barton PM; Logan J; Kavalier F; Harris HJ; Johnston TA; Anionwu EN; Davis V; Brown K; Juarez-Garcia A; Tsianakas V; Marteau TM
    Health Technol Assess; 2010 Apr; 14(20):1-160. PubMed ID: 20416236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal screening for cystic fibrosis: a trial of the couple model.
    Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
    BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
    Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
    BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of antenatal screening for cystic fibrosis. Realistic cost must be established for genetic counselling in two step screening.
    Brock DJ
    BMJ; 1996 Apr; 312(7035):908; author reply 910. PubMed ID: 8611893
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost comparison of different methods of screening for cystic fibrosis.
    Morris JK; Oppenheimer PM
    J Med Screen; 1995; 2(1):22-7. PubMed ID: 7497140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-effectiveness analysis of prenatal carrier screening for cystic fibrosis.
    Vintzileos AM; Ananth CV; Smulian JC; Fisher AJ; Day-Salvatore D; Beazoglou T
    Obstet Gynecol; 1998 Apr; 91(4):529-34. PubMed ID: 9540935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning the development of cystic fibrosis gene carrier screening.
    Beech R; Bekker H
    J Health Serv Res Policy; 1996 Apr; 1(2):81-92. PubMed ID: 10180854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness analysis of antenatal HIV screening in United Kingdom.
    Ades AE; Sculpher MJ; Gibb DM; Gupta R; Ratcliffe J
    BMJ; 1999 Nov; 319(7219):1230-4. PubMed ID: 10550083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier screening for cystic fibrosis: costs and clinical outcomes.
    Asch DA; Hershey JC; Dekay ML; Pauly MV; Patton JP; Jedrziewski MK; Frei F; Giardine R; Kant JA; Mennuti MT
    Med Decis Making; 1998; 18(2):202-12. PubMed ID: 9566453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stepwise or couple antenatal carrier screening for cystic fibrosis?: women's preferences and willingness to pay.
    Miedzybrodzka Z; Semper J; Shackley P; Abdalla M; Donaldson C
    J Med Genet; 1995 Apr; 32(4):282-3. PubMed ID: 7643357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis.
    Maxwell S; Brameld K; Youngs L; Geelhoed E; O'Leary P
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):51-9. PubMed ID: 20218998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.